Stay updated with breaking news from Enforcement Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Takeaways - The FDA’s Patient Engagement Advisory Committee, organized under the Center for Devices and Radiological Health (“CDRH”), held a public meeting on October 6, 2021, to...
Cipla recalls 7,228 bottles of overactive bladder treatment drug in America SECTIONS Last Updated: Jul 25, 2021, 12:27 PM IST Share Synopsis As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. ThinkStock Photos Drug major Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market due to manufacturing issues. As per...
Wyoming issues 325 fishing without a license, 127 waste of big game citations in 2020 By Brendan LaChance on July 12, 2021 (Shutterstock) CASPER, Wyo. — The Wyoming Game and Fish Department announced the release of their 2020 Law Enforcement Report on Monday, July 12, 2021. The report shows that Game and Fish took a total of 4,106 law enforcement actions in 2020, with the top ten violations as follows: Fishing without a license — 325 Hunt, fish, trap, collect shed antlers on private land without permission (trespassing) — 284 Violation of rules governing use of Department-administer...
Explore Now Nifty futures on the Singapore Exchange traded 128 points, or 0.87 per cent, lower at 14,513.50 in signs that Dalal Street was headed for a negative start on Monday. Here are a few stocks which may buzz the most in today's trade: Macrotech Developers: Shares of the realtor, which recently raised Rs 2,500 crore through a public issue, will list its shares on stock exchanges on April 19. The Mumbai-based company launched its initial public offering (IPO) on April 7 to raise Rs 2,500 crore through fresh issue of shares. The issue, which had a price band of Rs 483-486 per share, clos...
Sun Pharma, Alembic recall products in US market SECTIONS Last Updated: Apr 18, 2021, 11:47 AM IST Share Synopsis According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019. According to the US regulator, a class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences". Related NSE Explore Now NEW DELHI: Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products in the US, the world's largest market for medicines. As per t...